Evaluation of survival rate and prognostic indicators for surgical treatment of left-to-right patent ductus arteriosus in dogs: 52 Cases (1995-2003)

Journal of the American Veterinary Medical Association

Volumn 227, Issue 11, 2005, Pages 1794-1799

  Bureau, Stéphane ^a   Monnet, Eric ^b   Orton, E Christopher ^b  

^a Colorado State University ^*

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE; BODY WEIGHT; BREED; CLINICAL EXAMINATION; CONTROLLED STUDY; DOG; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT RIGHT SHUNT; HEART MURMUR; HEART VENTRICLE TACHYCARDIA; INTERVIEW; LETHARGY; LUNG EDEMA; MALE; MITRAL VALVE REGURGITATION; NONHUMAN; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY;

ANIMALS; DOG DISEASES; DOGS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; HEART; MALE; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 28444448339     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.227.1794     Document Type: Review

References (29)

1. Tidholm A. Retrospective study of congenital heart defects in 151 dogs. J Small Anim Pract 1997;38:94-98.
2. Buchanan JW. Patent ductus arteriosus. Semin Vet Med Surg (Small Anim) 1994;9:168-176.
3. Goodwin JK, Cooper RCJ. Understanding the pathophysiology of congenital heart defects. Vet Med 1992;87:650-668.
4. Buchanan JW. Patent ductus arteriosus morphology, pathogenesis, types and treatment. J Vet Card 2001;3:7-16.
5. Weirich WE, Blevins WE, Rebar AH. Late consequences of patent ductus arteriosus in the dog: a report of six cases. J Am Anim Hosp Assoc 1978;14:40-51.
6. Corti LB, Merkley D, Nelson OL, et al. Retrospective evaluation of occlusion of patent ductus arteriosus with hemoclips in 20 dogs. J Am Anim Hosp Assoc 2000;36:548-555.
7. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-1598.
8. Van Israel N, Dukes-McEwan J, French AT. Long-term follow-up of dogs with patent ductus arteriosus. J Small Anim Pract 2003;44:480-490.
9. Sisson D: Use of a self-expanding occluding stem for non-surgical closure of patent ductus arteriosus in dogs. J Am Vet Med Assoc 2003;223:999-1005.
10. Stanley BJ, Luis-Fuentes V, Darke PG. Comparison of the incidence of residual shunting between two surgical techniques used for ligation of patent ductus arteriosus in the dog. Vet Surg 2003; 32:231-237.
11. Borenstein N, Behr L, Chetboul V, et al. Minimally invasive patent ductus arteriosus occlusion in 5 dogs. Vet Surg 2004;33:309-313.
12. Eyster GE, Eyster JT, Cords GB, et al. Patent ductus arteriosus in the dog: characteristics of occurence and results of surgery on one hundred consecutive cases. J Am Vet Med Assoc 1976;168:435-438.
13. Birchard SJ, Bonagura JD, Fingland RB. Results of ligation of patent ductus arteriosus in dogs: 201 cases (1969-1988). J Am Vet Med Assoc 1990;196:2011-2013.
14. Smetzer DL, Breznock EM. Auscultatory diagnosis of patent ductus arteriosus in the dog. J Am Vet Med Assoc 1972;160:80-84.
15. Van Israel N, French AT, Dukes-McEwan J, et al. Review of left-to-right shunting patent ductus arteriosus and short term outcome in 98 dogs. J Small Anim Pract 2002;43:395-400.
16. Van Israel N, French AT, Dukes-McEwan J, et al. Patent ductus arteriosus in the older dog. J Vet Card 2003;5:13-20.
17. Goodwin J, Lombard CW. Patent ductus arteriosus in adult dogs: clinical features of 14 cases. J Am Anim Hosp Assoc 1992;28: 349-354.
18. Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. J Am Vet Med Assoc 1998;213:1573-1577.
19. The CONSENSUS Trial Study Group. Effects of enalapril on mortality of severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
20. Häggström J, Hansson K, Karlberg BE, et al. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin- aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am J Vet Res 1996;57:1645-1652.
21. Hamlin RL, Benitz AM, Ericsson GF, et al. Effects of enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation. J Vet Intern Med 1996;10:85-87.
22. Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:80-88.
23. Kastor JA. Atrial fibrillation. In: Kastor JA, ed. Arrhythmias. Philadelphia: WB Saunders Co, 1994;27-104.
24. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001;104:159-163.
25. Buchanan JW, Bucheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc 1995;206: 194-199.
26. Lamb CR, Boswood A, Volkman A, et al. Assessment of survey radiograph as a method for diagnosis of congenital cardiac disease in dogs. J Small Anim Pract 2001;42:541-545.
27. Hunt GB, Simpson DJ, Beck JA, et al. Intraoperative hemorrhage during patent ductus arteriosus ligation in dogs. Vet Surg 2001; 30:58-63.
28. Hunter SL, Culp LB, Muir WW III, et al. Sodium nitroprus-side-induced deliberate hypotension to facilitate patent ductus arteriosus ligation in dogs. Vet Surg 2003;32:336-340.
29. Romeo F, Pelliccia F, Cianfrocca C, et al. Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol 1989;12:387-392.